The Long Run with Luke Timmerman cover image

Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery

The Long Run with Luke Timmerman

00:00

Is Small Molecule a Better Modality Than a Biologic?

Ess: Small molecule has certain advantages, like the lower cost of goods. One of the biggest is patient compliance. Biologics have revolutionized health care. They validate the target thit's a great opportunity.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app